Related Experiment Videos

Management of localised prostate cancer: state of the art

M Frydenberg, G Duchesne, P D Stricker

The Medical Journal of Australia

|August 8, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Eight-year outcomes of testosterone suppression plus enzalutamide or a nonsteroidal antiandrogen for metastatic hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial.

Pathology·2021

Cancer-associated fibroblasts of the prostate promote a compliant and more invasive phenotype in benign prostate epithelial cells.

Materials today. Bio·2020

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

A novel method of bladder neck imbrication to improve early urinary continence following robotic-assisted radical prostatectomy.

Journal of robotic surgery·2016

See all related articles